AstraZeneca COVID-19 vaccine applies for full regulatory approval in Brazil
RIO DE JANEIRO (Reuters) - Brazilian health regulator Anvisa said on Friday that a COVID-19 vaccine developed by Oxford University and AstraZeneca Plc had applied for full regulatory approval, in a positive development for the country's beleaguered vaccine rollout. Read full story
Comments
Post a Comment